NCT01430130

Brief Summary

Neodyne has developed an investigational dressing for post-operative incision care. Neodyne is conducting this research to study whether the investigational dressing, called the Neodyne Dressing, can minimize scar formation in a simple manner.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

September 6, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 7, 2011

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2012

Completed
2.1 years until next milestone

Results Posted

Study results publicly available

November 28, 2014

Completed
Last Updated

November 28, 2014

Status Verified

November 1, 2014

Enrollment Period

1.2 years

First QC Date

September 6, 2011

Results QC Date

November 10, 2014

Last Update Submit

November 21, 2014

Conditions

Keywords

scarincisionwound healingscarringscar revision

Outcome Measures

Primary Outcomes (1)

  • Visual Analogue Scale (VAS)

    Visual Analogue Scale Scar Score (VAS Scar Score) was defined and validated by Duncan et al 2006\[1\]. This scale consists of a 10cm line representing scar quality, with 0 representing normal skin and 10 indicating a poor scar. The assessor places a mark along the line to represent the appearance of the scar. This mark is translated into a score by measuring its position on the 10cm line to one decimal place. The independent panel used this to scale the primary outcome. \[1\] Duncan J, Bond J, Mason T, Ludlow A, Cridland P, O'Kane S and Ferguson M. Visual Analogue Scale Scoring and Ranking: A Suitable and Sensitive Method for Assessing Scar Quality? Plast. Reconstr. Surg. 118: 909, 2006.

    6 months

Secondary Outcomes (4)

  • Subject and Investigator Satisfaction With the Aesthetic Results

    Up to 12 months

  • Ease of Use

    Up to 12 months

  • Comfort Level Related to Study Device Application, Wear and Removal

    Up to 12 weeks

  • Comparison of Scar Smoothness of Treated Side as Compared to the Control Side

    Up to 12 months

Study Arms (1)

All Study Participants

EXPERIMENTAL

Half of the revised incision was treated with the embrace device. Half of the revised incision was treated according to the Investigator's standard of care. Participant served as his/her own control.

Device: embrace device

Interventions

Adhesive bandage/dressing intended to minimize scar formation.

Also known as: Neodyne dressing
All Study Participants

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The scar to be revised is:
  • at least 12 months old
  • linear and suitable for revision by excision and direct closure
  • appropriate size and location for Neodyne Dressing
  • The subject:
  • age \> 18 and \< 65 years old

You may not qualify if:

  • Subjects with a skin disorder that is chronic or currently active.
  • Subjects who are involved in ongoing litigation in connection with the scar to be revised.
  • Subjects with a history of collagen vascular disease
  • Subjects diagnosed with scleroderma
  • Subject who currently smokes
  • Subjects with known adverse reactions to steri-strip tapes, medical tapes, or adhesives
  • Subjects with oozing, dehiscence, non-closed/healed incisions at time of first application.
  • Subjects with inability to maintain adequate care of incision.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duet Plastic Surgery

Palo Alto, California, 94306, United States

Location

MeSH Terms

Conditions

HypertrophyCicatrixSurgical Wound

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsFibrosisPathologic ProcessesWounds and Injuries

Limitations and Caveats

The Neodyne Dressing is referred to as the "embrace device."

Results Point of Contact

Title
Kristin Prosak
Organization
Neodyne Biosciences

Study Officials

  • Jennifer Weintraub, MD

    Duet Plastic Surgery

    PRINCIPAL INVESTIGATOR
  • Angeline Lim, MD

    Duet Plastic Surgery

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 6, 2011

First Posted

September 7, 2011

Study Start

September 1, 2011

Primary Completion

November 1, 2012

Study Completion

November 1, 2012

Last Updated

November 28, 2014

Results First Posted

November 28, 2014

Record last verified: 2014-11

Locations